Home › Cases › Nosebleed on a DOAC — Deciding Who Goes Home
Epistaxis
Nosebleed on a DOAC — Deciding Who Goes Home
6 questions
Question 1 · Who Is High Risk
Correct answer: High risk — elderly and anticoagulated is explicitly the high-risk combination, and recurrent bleeding today
Why
Elderly plus anticoagulated equals high risk. The pathway names that combination directly.
- Recurrent bleeding on the same day means the bleeding point has not been controlled — it has only paused
- IV access, FBC, coagulation and INR, group and save if heavy
- Normal observations now are reassuring about what has happened, not about what happens at 03:00
- You can and should risk-assess her yourself; that is not something to defer to ENT
Key point
Elderly + anticoagulated = high risk, even between episodes. Stopping three times means it has not stopped.
Question 2 · DOAC Versus Warfarin
Correct answer: INR does not usefully reflect DOAC effect — check FBC and renal function, and establish the timing of her last dose
Why
INR does not usefully measure DOAC anticoagulation, and vitamin K does not reverse it.
- Check FBC and renal function — DOAC clearance is renal-dependent, so an AKI meaningfully prolongs the effect
- Establish when the last dose was taken; effect wanes over hours, which shapes the plan
- "No monitoring required" is true for routine dosing and untrue in active bleeding
- Hold the DOAC if bleeding persists, as the pathway directs for warfarin and DOACs alike
Key point
INR does not measure a DOAC and vitamin K does not reverse it. Check renal function and the last dose time.
Question 3 · Finding the Point
Correct answer: Cauterise the visible point with silver nitrate, one side only
Why
Cauterise the visible point — silver nitrate 75%, one side of the septum only, 5–10 seconds around the point.
- Treating a visible vessel between episodes is exactly the opportunity you want, and it is more controlled than doing it mid-haemorrhage
- Waiting for active bleeding gives up the best conditions you will get
- Prophylactic bilateral packing is wrong on both counts: it is unnecessary, and bilateral intervention on the septum carries the perforation risk the pathway warns about
Key point
A visible point between episodes is the best time to cauterise, not a reason to wait.
Question 4 · Aftercare
Correct answer: Naseptin cream QDS for 10 days — check for peanut allergy, as it contains peanut oil
Why
Naseptin QDS for 10 days after control reduces recurrence — and it contains peanut oil, so check for peanut allergy.
- It is the kind of detail that is easy to skip and occasionally causes real harm
- Routine systemic antibiotics are not indicated after simple cautery
- Topical vasoconstrictors are for supervised clinical use during examination and cautery, not for home use
Key point
Naseptin contains peanut oil. Ask about peanut allergy before you prescribe it.
Question 5 · Home or Not
Correct answer: Weigh recurrent bleeding, anticoagulation, age and living alone; discuss with ENT and have a low threshold for admission or a clear same-day review
Why
Admission is not automatic after cautery — but the threshold in this patient is low.
- The pathway's explicit admission rule is for packed anticoagulated patients; she has been cauterised, not packed
- Against discharge: three bleeds today, anticoagulated, 79, living alone — nobody would find her if she rebled overnight
- Discharge, if chosen, needs explicit return instructions, working first aid technique she can demonstrate, and a named ENT follow-up
- Blanket admission of every anticoagulated nosebleed is neither the guidance nor practical
Key point
Packed and anticoagulated is an automatic admission. Cauterised is a judgement — and living alone weighs heavily.
Question 6 · The Anticoagulant Question
Correct answer: It is held during active bleeding, but stopping it long-term is a balance-of-risks decision about her stroke risk, made with the team who prescribed it
Why
Hold it while she is bleeding; the long-term question belongs to the people managing her AF.
- The pathway directs holding warfarin or a DOAC if bleeding persists — that is a short-term measure
- Stopping it permanently trades a controllable nosebleed for an uncontrollable stroke, and that arithmetic needs her actual stroke risk, not a general instinct
- Never interrupting is equally wrong — active haemorrhage is exactly when you hold it
- Document the plan and who will review it, so the decision does not simply drift
Key point
Hold it now, decide later, and say who decides. Trading a nosebleed for a stroke is not a ward-level call.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.